The Motley Fool··Reuben Gregg BrewerTeva Pharmaceutical Faces Structural Challenges Amid Strategic Pivot
Teva Pharmaceutical faces margin compression in generic drugs, pivoting toward complex generics and original drug development. Limited financial flexibility creates elevated execution risk.
PFETEVAGLP-1 drugsdrug development